(firstQuint)Asacol Acute Diverticulitis(DIVA)Study.

 This study is designed to evaluate the safety and efficacy of Asacol(R) 2.

4 g/day in generally healthy, adult patients who have had an attack of acute diverticulitis.

 The study will evaluate the safety and efficacy of a 12 week treatment with Asacol(R) followed a 9 month non-treatment observation period in approximately 180 patients with acute diverticulitis.

.

 Asacol Acute Diverticulitis(DIVA)Study@highlight

The purpose of this study is to determine whether Asacol(R) 2.

4 g/day (400 mg Mesalamine) is safe and effective in the treatment of diverticulitis.

